What is the recommended dose of phloroglucinol for children (≥2 years old), including weight‑based dosing, maximum single and daily limits, and repeat interval?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Phloroglucinol Dosing in Pediatrics

Based on available FDA labeling, phloroglucinol is dosed as three pills daily in children, taken 30 minutes after food 1. However, this represents extremely limited pediatric-specific guidance, and critical dosing parameters are absent.

Critical Evidence Gaps

The provided evidence reveals a significant lack of pediatric dosing information for phloroglucinol:

  • No weight-based dosing guidelines are available in the FDA labeling
  • No age-specific dose adjustments are provided beyond generic "adult or child" language 1
  • No maximum single or daily dose limits are specified for pediatric patients
  • No repeat interval guidance beyond "three times daily"
  • The only safety guidance is to "keep out of reach of children" 1, which is standard language rather than dosing instruction

Clinical Context and Limitations

The research evidence demonstrates phloroglucinol's use in adults for:

  • Abdominal pain and spasms (urinary/biliary colic) 2
  • Irritable bowel syndrome at 50mg three times daily 3
  • Anti-inflammatory effects through immune modulation 4

However, none of the research studies included pediatric populations for dosing determination. The systematic review 5 found insufficient evidence even for adult abdominal pain efficacy versus placebo.

Practical Approach Given Evidence Limitations

In the absence of robust pediatric dosing data, extreme caution is warranted:

  • The generic "three pills daily" recommendation 1 lacks the specificity required for safe pediatric prescribing
  • Without weight-based or age-stratified dosing, risk of under- or overdosing is substantial
  • The pharmacokinetic data 6 shows poor systemic bioavailability and extensive metabolism, but this was studied only in adults
  • General pediatric dosing principles 7 suggest drugs should be normalized to body surface area after 6 months of age, but phloroglucinol-specific data are absent

Given these limitations, phloroglucinol cannot be recommended for routine pediatric use without consulting specialized references or poison control for specific dosing guidance, as the available evidence does not provide adequate safety parameters for children.

Related Questions

What is the recommended adult dose of phloroglucinol and when is a 160 mg dose appropriate?
What is the recommended dose of Avil (pheniramine) injection for an 8-year-old boy weighing 28kg?
What are the dosing guidelines, contraindications, and safety considerations for Bromfed (brompheniramine/phenylephrine)?
How many times a day can Bromfed (Brompheniramine) be administered to children?
What are the recommended dosing guidelines, indications, and safety monitoring for amitriptyline in children aged 6–12 years?
What are the safety concerns of levetiracetam and can an overdose be fatal?
In a patient with Q waves in leads V1 and V2 on the electrocardiogram, could this represent a normal variant or does it suggest a possible septal myocardial infarction requiring further evaluation?
In a patient with hypermobile Ehlers‑Danlos syndrome, postural orthostatic tachycardia syndrome, and mast cell activation syndrome who sleeps on their side, is it normal to have significant hip pain that causes them to roll over every 30–60 minutes during the night?
Can melatonin be taken concurrently with a serotonin-norepinephrine reuptake inhibitor (SNRI)?
A 23-year-old man who smokes 20 cigarettes per day presents with dyspnea, facial flushing, jugular venous distention, anterior chest wall venous engorgement, painless cervical lymphadenopathy, and neck pain that occurs immediately after alcohol consumption; what is the most likely diagnosis?
What are the indications, dosing regimen, premedication, monitoring requirements, and contraindications for pegloticase in adults with chronic refractory gout?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.